Covid Vaccination In India

AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.

The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.

Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.

Bill Gates also appreciated India as a global innovator, contributing valuable solutions to global health problems.

India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.

Three new deaths due to Covid-- one each from Kerala, Karnataka and Bihar -- have been reported in 24 hours.

Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.

This JN.1 variant is causing a surge in infections worldwide yet again and raising alarm bells among health authorities.

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.

COVID-19 caused an alarming surge in premature births, but vaccines were key to returning the early birth rate to pre-pandemic levels, researchers have found analysing birth records in California, US.

Vaccines administered for COVID-19 did not increase the risk of sudden death among young adults in India, according to a peer-reviewed ICMR study.

The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in

The research, published recently in the journal PLOS One, determined the impact of COVID-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.

Congress MP Rahul Gandhi's colleague who is in charge of the party's social media and digital platforms came to his defence today after Home Minister Amit Shah attacked the MP over COVID-19 vaccination.

AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.

The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.

Researchers have examined a man in Germany who claims to have received 217 vaccinations against COVID-19 and found that his immune system was fully functional.

Bill Gates also appreciated India as a global innovator, contributing valuable solutions to global health problems.

India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.

Three new deaths due to Covid-- one each from Kerala, Karnataka and Bihar -- have been reported in 24 hours.

Amid a surge in COVID-19 cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is needed against the subvariant at present.

This JN.1 variant is causing a surge in infections worldwide yet again and raising alarm bells among health authorities.

A study conducted by the Indian Council of Medical Research (ICMR) has observed that COVID-19 vaccination did not increase the risk of unexplained sudden death among young adults in India, the government informed Parliament on Friday.

COVID-19 caused an alarming surge in premature births, but vaccines were key to returning the early birth rate to pre-pandemic levels, researchers have found analysing birth records in California, US.

Vaccines administered for COVID-19 did not increase the risk of sudden death among young adults in India, according to a peer-reviewed ICMR study.

The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in

The research, published recently in the journal PLOS One, determined the impact of COVID-19 vaccination on mortality following acute myocardial infarction (AMI) or heart attack.

Congress MP Rahul Gandhi's colleague who is in charge of the party's social media and digital platforms came to his defence today after Home Minister Amit Shah attacked the MP over COVID-19 vaccination.